Heart Surg Forum
. 2020 Jun 15;23(4):E426-E429.
doi: 10.1532/hsf.2959.
Progress in Treatment of Myocardial Injury in Patients with 2019-nCoV: A Chinese Experience
Shixiong Wei 1 , Lin Zhang 2 , Huimin Cui 2 , Shengli Jiang 2
Affiliations
- PMID: 32726217
- DOI: 10.1532/hsf.2959
Abstract
Since December 2019, the 2019 novel coronavirus (2019-nCoV) infection began to appear in Hubei Province of China and gradually spread to other provinces and other countries. The virus has the characteristics of strong transmission capacity, diverse clinical manifestations, long incubation period, and latent infection, thus posing a serious threat to human life safety and health. With the increasing number of cases and the continuous enrichment of clinical data, 2019-nCoV-infected patients have received more and more attention regarding myocardial injury related to virus infection besides typical respiratory system manifestations. According to the published data, we summarize the myocardial injury manifestations, characteristics, effects on disease condition, and prognosis of 2019-nCoV-infected patients and discuss the possible injury mechanism, treatment methods, and future research directions.